mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
Imatinib |
FIMM |
pan-cancer |
AAC |
0.19 |
0.3 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |